Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Type 2 Diabetes Mellitus(T2DM)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)WithdrawnNCT03423355
What this trial is testing

Dapagliflozin Effect on Erythropoiesis and Physical Fitness

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)
University Hospital Tuebingen
Large-scale testing (Phase 3)Looking for participantsNCT06716216
What this trial is testing

BGM0504 in Participants with Type 2 Diabetes

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)
BrightGene Bio-Medical Technology Co., Ltd. 537
Early research (Phase 1)Looking for participantsNCT07630233
What this trial is testing

A Phase I Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Subcutaneous UBT38006 Injection in Healthy Adult Males

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)
The United Bio-Technology (Hengqin) Co., Ltd. 53
Early research (Phase 1)UnknownNCT05369078
What this trial is testing

Safety, Tolerance and Pharmacokinetics of THR-1442 in Chinese Healthy Subjects

Who this might be right for
T2DM (Type 2 Diabetes Mellitus)
Newsoara Biopharma Co., Ltd. 16
Testing effectiveness (Phase 2)Study completedNCT06393348
What this trial is testing

Efficacy and Safety of HRS-7535 Tablets in T2DM Subjects Poorly Controlled With Metformin and SGLT2i.

Who this might be right for
Type 2 Diabetes
Shandong Suncadia Medicine Co., Ltd. 155
Not applicableNot Yet RecruitingNCT07794384
What this trial is testing

Effects of a Researcher-Designed Diabetes Self-Management App on Self-Management Obstacles, Self-Efficacy, and Physiological Indicators in Type 2 Diabetes

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)Self-management
Fu Jen Catholic University Hospital 80
Not applicableNot Yet RecruitingNCT07567378
What this trial is testing

CARTIZ Registry: Cartilage, Arthropathy and Imaging Under Tirzepatide in Zone-stratified Cohorts - A Four-Institute Mexican Observational Registry

Who this might be right for
Psoriatic ArthritisOsteoarthitisKnee+12 more
JULIO GRANADOS MONTIEL 30
Early research (Phase 1)Study completedNCT05294458
What this trial is testing

A Randomised, Open-Label Study to Evaluate the Relative and Absolute Bioavailability of Cotadutide in Healthy Subjects

Who this might be right for
Non-alcoholic SteatohepatitisType 2 Diabetes Mellitus (T2DM)Chronic Kidney Disease
AstraZeneca 10
Large-scale testing (Phase 3)UnknownNCT03811548
What this trial is testing

Janagliflozin Treat T2DM Monotherapy

Who this might be right for
Diabetes Type 2
Sihuan Pharmaceutical Holdings Group Ltd. 442
Large-scale testing (Phase 3)Active Not RecruitingNCT06778967
What this trial is testing

A Phase III Clinical Study to Evaluate the Efficacy and Safety of GZR18 Injection in Adult Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)
Gan & Lee Pharmaceuticals. 1,100
Not applicableStudy completedNCT00205738
What this trial is testing

Janssen - Glucose Regulation/Risp/Olanz

Who this might be right for
SchizophreniaType 2 Diabetes Mellitus
Washington University School of Medicine 120
Testing effectiveness (Phase 2)Study completedNCT06256523
What this trial is testing

GZR18 Injection in Chinese Adult Patients With Type 2 Diabetes Mellitus (T2DM)

Who this might be right for
Type 2 Diabetes
Gan and Lee Pharmaceuticals, USA 72
Not applicableStudy completedNCT00205725
What this trial is testing

Pfizer/IVGTT/Ziprasidone/Olanzapine

Who this might be right for
SchizophreniaType 2 Diabetes Mellitus
Washington University School of Medicine 120
Large-scale testing (Phase 3)Study completedNCT06571591
What this trial is testing

Efficacy and Safety of Pioglitazone Combination Therapy in Type 2 Diabetes Patients on a Background of Empagliflozin With Metformin

Who this might be right for
T2DM
Celltrion 606
Testing effectiveness (Phase 2)Study completedNCT06059326
What this trial is testing

Multiple-dose Study to Evaluate the Safety,Tolerability, Pharmacokinetics and Pharmacodynamics of HSK7653 in T2DM

Who this might be right for
Type 2 Diabetes Mellitus
Haisco Pharmaceutical Group Co., Ltd. 48
Not applicableNot Yet RecruitingNCT07595289
What this trial is testing

DP-DCT 1.0：A Comparative Clinical Study on the Effect of Dapagliflozin Combined With CGM Versus SMBG on Glycemic Control in Patients With Type 2 Diabetes Mellitus Based on the DP-DCT Platform

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)
The Third Xiangya Hospital of Central South University 120
Testing effectiveness (Phase 2)Study completedNCT03741660
What this trial is testing

Konjac-Mannan Improves Glycemia and Other Risk Factors for CHD in T2DM

Who this might be right for
Type2 DiabetesCoronary Heart Disease
Unity Health Toronto 11
Post-approval studies (Phase 4)Study completedNCT02325960
What this trial is testing

A Comparison of Exenatide and Insulin Glargine

Who this might be right for
Type 2 Diabetes
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 44
Testing effectiveness (Phase 2)Study completedNCT01885260
What this trial is testing

Safety, Tolerability and Efficacy of ISIS-GCGRRx in Type 2 Diabetes

Who this might be right for
Type 2 Diabetes Mellitus
Ionis Pharmaceuticals, Inc. 77
Not applicableStudy completedNCT05607160
What this trial is testing

Observe How Insulin Glargine 300 U/ml is Working and is Tolerated in Elderly Patients ≥75 Years of Age With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)
Sanofi 82
Next Page